1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 513 F.Supp.2d
  5. 513 F.Supp.2d 34 (2007)
 

AMGEN, INC. v. ARIAD PHARMACEUTICALS, INC.

Civ. A. No. 06-259-MPT.

513 F.Supp.2d 34 (2007)

AMGEN, INC., Immunex Corporation Amgen USA Inc., Amgen Manufacturing Limited, Immunex Rhode Island Corporation, Plaintiffs, v. ARIAD PHARMACEUTICALS, INC., Defendant.

United States District Court, D. Delaware.

March 27, 2007.

Attorney(s) appearing for the Case

Melanie K. Sharp, Young, Conaway, Stargatt & Taylor, Wilmington, DE, Mark A. Pals, Marcus E. Sernel, Chicago, IL, Robert G. Krupka, Drew Diamond, Los Angeles, CA, for Plaintiffs Amgen Inc., Immunex Corporation, Amgen USA, and Immunex Rhode Island Corp., of counsel.

John G. Day, Steven J. Balick, and Tiffany Geyer Lydon, Ashby & Geddes, Wilmington, DE, Morgan Chu, David I. Gindler, Elizabeth L. Rosenblatt, Irell & Manella, LLP, Los Angeles, CA, for Defendant Ariad Pharmaceuticals Inc., of counsel.

MEMORANDUM OPINION

THYNGE, United States Magistrate Judge.

I. Introduction

On April 20, 2006, Amgen Inc. and related entities (collectively "Amgen") filed a declaratory judgment action asserting that each claim of U.S. Patent No. 6,410,516 ("`516 patent") is invalid. The '516 patent is owned by the Massachusetts Institute of Technology ("MIT"), the Whitehead Institute for Biomedical Research ("Whitehead"), and the President and...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases